🎗️ OncologyInjection (IV)
Breyanzi
Lisocabtagene Maraleucel
CD19-directed CAR T-cell therapy for relapsed/refractory large B-cell lymphoma, CLL, and follicular lymphoma.
Form
Injection (IV)
Uses
3
Side effects
4
Category
Oncology
01
What is Breyanzi used for?
- Relapsed/refractory large B-cell lymphoma
- CLL/SLL
- Follicular lymphoma
02
Lisocabtagene Maraleucel side effects
The following side effects have been reported for Lisocabtagene Maraleucel. Their order does not indicate how often an effect occurs.
Cytokine release syndrome
Neurotoxicity (ICANS)
Infections
Prolonged cytopenias
03
Lisocabtagene Maraleucel warnings & precautions
- Black box: CRS and neurological toxicities
- REMS required
- Secondary malignancies including T-cell lymphoma reported
Loading FDA data…
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand Breyanzi in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.